| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |